دورية أكاديمية
أعرض في EDS

The association between weight-adjusted waist circumference index and cardiovascular disease and mortality in patients with diabetes.

التفاصيل البيبلوغرافية
العنوان: The association between weight-adjusted waist circumference index and cardiovascular disease and mortality in patients with diabetes.
المؤلفون: Tao Z; Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.; School of Medicine, Southeast University, Nanjing, China., Zuo P; Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China. zuopengfei1207@sina.com.; School of Medicine, Southeast University, Nanjing, China. zuopengfei1207@sina.com., Ma G; Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China. magenshan@hotmail.com.; School of Medicine, Southeast University, Nanjing, China. magenshan@hotmail.com.
المصدر: Scientific reports [Sci Rep] 2024 Aug 16; Vol. 14 (1), pp. 18973. Date of Electronic Publication: 2024 Aug 16.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Waist Circumference* , Cardiovascular Diseases*/mortality , Diabetes Mellitus*/mortality , Diabetes Mellitus*/epidemiology , Nutrition Surveys*, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Body Weight ; Risk Factors ; ROC Curve ; Prevalence
مستخلص: Cardiovascular disease (CVD) is a significant health concern, particularly among patients with diabetes. The weight-adjusted waist circumference index (WWI), a novel metric that accounts for central obesity, has shown potential in predicting obesity-related health risks. This study aimed to evaluate the association of WWI with CVD and mortality in patients with diabetes. Utilizing data from the National Health and Nutrition Examination Survey from 1999 to 2020, WWI was calculated by dividing waist circumference (WC) by the square root of body weight. Multivariate logistic regression, multivariate Cox regression and restricted cubic spline curves were used to assess the association between WWI and the prevalence of CVD and mortality in patients with diabetes, subgroup and sensitivity analyses were carried out to delve into the stability of the findings. The predictive performance of WWI was evaluated using the area under the receiver operating characteristic curve (ROC). This study included 8,005 individuals with diabetes. With the increase in WWI values, the risk of developing CVD and the likelihood of mortality progressively rise. The fully adjusted continuous model indicated a 28% higher chance of developing CVD and a 25% higher risk of all-cause mortality for each one-unit increase in WWI. When using the lowest quartile of WWI as the reference category, the highest quartile was linked to an increased risk of CVD (OR 1.66; 95% CI 1.10-2.50, p = 0.015) and all-cause mortality (HR 1.53, 95% CI 1.27-1.83, p < 0.001) among patients with diabetes. Subgroup and sensitivity analyses confirmed that these associations were consistent and stable in most different demographics. The ROC analysis indicated that WWI had a higher predictive capacity for CVD and all-cause mortality than WC, waist to hip ratio, and weight to height ratio. The WWI was significantly associated with the prevalence of CVD and all-cause mortality among patients with diabetes in the United States and may serve as a useful tool for identifying individuals at risk.
(© 2024. The Author(s).)
References: Diabetes Care. 2013 Jan;36 Suppl 1:S11-66. (PMID: 23264422)
BMC Cardiovasc Disord. 2023 Sep 1;23(1):435. (PMID: 37658325)
Front Physiol. 2018 Aug 21;9:1030. (PMID: 30246793)
Front Cardiovasc Med. 2022 Dec 14;9:1069146. (PMID: 36588556)
J Clin Lipidol. 2020 Jul - Aug;14(4):531-541. (PMID: 32651087)
BMC Cardiovasc Disord. 2014 Dec 06;14:176. (PMID: 25480761)
Circulation. 2020 Mar 3;141(9):e139-e596. (PMID: 31992061)
Front Cardiovasc Med. 2022 Sep 14;9:948194. (PMID: 36186965)
Circulation. 2001 Nov 27;104(22):2673-8. (PMID: 11723017)
G Ital Cardiol (Rome). 2020 Apr;21(4):246-251. (PMID: 32202554)
Cardiovasc Diabetol. 2023 Apr 1;22(1):80. (PMID: 37005586)
Cardiovasc Diabetol. 2022 May 14;21(1):74. (PMID: 35568946)
Eur J Clin Nutr. 2010 Mar;64(3):239-44. (PMID: 20087373)
Diabetes Metab J. 2022 Sep;46(5):747-755. (PMID: 35350091)
Circulation. 2015 Dec 1;132(22):2134-45. (PMID: 26362633)
Redox Biol. 2019 Jan;20:247-260. (PMID: 30384259)
Cardiovasc Diabetol. 2024 May 16;23(1):171. (PMID: 38755682)
Circulation. 2012 Sep 4;126(10):1301-13. (PMID: 22949540)
Antioxidants (Basel). 2021 May 05;10(5):. (PMID: 34063078)
Mayo Clin Proc. 2011 Sep;86(9):857-64. (PMID: 21878597)
Pharmacol Res. 2016 Nov;113(Pt A):600-609. (PMID: 27697647)
Circulation. 2021 May 25;143(21):e984-e1010. (PMID: 33882682)
Front Physiol. 2018 Jun 26;9:758. (PMID: 29997521)
Hypertens Res. 2023 Jan;46(1):253-260. (PMID: 36319736)
Lancet. 2005 Oct 1;366(9492):1197-209. (PMID: 16198769)
Curr Cardiol Rep. 2020 Mar 12;22(4):25. (PMID: 32166448)
Lancet. 2016 Apr 2;387(10026):1377-1396. (PMID: 27115820)
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2196-2203. (PMID: 37550773)
JACC Cardiovasc Imaging. 2021 Feb;14(2):426-438. (PMID: 33129736)
JAMA. 2014 Sep 17;312(11):1151-3. (PMID: 25226482)
Front Endocrinol (Lausanne). 2024 Mar 15;15:1345411. (PMID: 38559695)
J Orthop Surg Res. 2023 Apr 10;18(1):290. (PMID: 37038167)
Front Endocrinol (Lausanne). 2024 Jan 16;14:1325454. (PMID: 38292766)
Eur J Intern Med. 2023 Jul;113:57-68. (PMID: 37062642)
Age Ageing. 2021 May 5;50(3):780-786. (PMID: 33035293)
BMC Public Health. 2023 Sep 1;23(1):1689. (PMID: 37658310)
Sci Rep. 2018 Nov 13;8(1):16753. (PMID: 30425288)
J Clin Med. 2023 Feb 17;12(4):. (PMID: 36836156)
Circ Res. 2016 May 27;118(11):1808-29. (PMID: 27230643)
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. (PMID: 31301983)
Cardiovasc Diabetol. 2023 Oct 17;22(1):279. (PMID: 37848879)
Circulation. 2019 Mar 12;139(11):1384-1395. (PMID: 30586757)
Clinics (Sao Paulo). 2023 Jul 11;78:100248. (PMID: 37441866)
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. (PMID: 33309175)
Front Pharmacol. 2021 Nov 15;12:777083. (PMID: 34867407)
J Clin Invest. 2004 Dec;114(12):1752-61. (PMID: 15599400)
معلومات مُعتمدة: 82370346 National Natural Science Foundation of China
فهرسة مساهمة: Keywords: Cardiovascular disease; Diabetes; Mortality; NHANES; Obesity; Weight-adjusted waist circumference index
تواريخ الأحداث: Date Created: 20240816 Date Completed: 20240816 Latest Revision: 20240819
رمز التحديث: 20240819
مُعرف محوري في PubMed: PMC11329698
DOI: 10.1038/s41598-024-69712-w
PMID: 39152145
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-69712-w